Weibull prediction of event times in clinical trials

30Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In clinical trials with interim analyses planned at pre-specified event counts, one may wish to predict the times of these landmark events as a tool for logistical planning. Currently available methods use either a parametric approach based on an exponential model for survival (Bagiella and Heitjan, Statistics in Medicine 2001; 20:2055) or a non-parametric approach based on the Kaplan-Meier estimate (Ying et al., Clinical Trials 2004; 1:352). Ying et al. (2004) demonstrated the trade-off between bias and variance in these models; the exponential method is highly efficient when its assumptions hold buy potentially biased when they do not, whereas the non-parametric method has minimal bias and is well calibrated under a range of survival models but typical gives wider prediction intervals and may fail to produce useful predictions early in the trial. As a potential compromise, we propose here to make predictions under a Weibull survival model. Computations are somewhat more difficult than with the simpler exponential model, but Monte Carlo studies show that predictions are robust under a broader range of assumptions. We demonstrate the method using data from a trial of immunotherapy for chronic granulomatous disease. Copyright © 2007 John Wiley & Sons, Ltd.

Cite

CITATION STYLE

APA

Ying, G. S., & Heitjan, D. F. (2008). Weibull prediction of event times in clinical trials. Pharmaceutical Statistics, 7(2), 107–120. https://doi.org/10.1002/pst.271

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free